COO
Price
$105.92
Change
-$1.05 (-0.98%)
Updated
Oct 4 closing price
60 days until earnings call
WAT
Price
$352.51
Change
-$1.89 (-0.53%)
Updated
Oct 4 closing price
23 days until earnings call
Ad is loading...

COO vs WAT

Header iconCOO vs WAT Comparison
Open Charts COO vs WATBanner chart's image
Cooper Companies (The)
Price$105.92
Change-$1.05 (-0.98%)
Volume$1.05M
CapitalizationN/A
Waters
Price$352.51
Change-$1.89 (-0.53%)
Volume$576.38K
CapitalizationN/A
View a ticker or compare two or three
COO vs WAT Comparison Chart
Loading...
COO
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
WAT
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
COO vs. WAT commentary
Oct 06, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is COO is a StrongBuy and WAT is a Buy.

COMPARISON
Comparison
Oct 06, 2024
Stock price -- (COO: $105.92 vs. WAT: $352.51)
Brand notoriety: COO and WAT are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: COO: 95% vs. WAT: 155%
Market capitalization -- COO: $19.72B vs. WAT: $20.38B
COO [@Medical Specialties] is valued at $19.72B. WAT’s [@Medical Specialties] market capitalization is $20.38B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $7.87B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

COO’s FA Score shows that 1 FA rating(s) are green whileWAT’s FA Score has 3 green FA rating(s).

  • COO’s FA Score: 1 green, 4 red.
  • WAT’s FA Score: 3 green, 2 red.
According to our system of comparison, WAT is a better buy in the long-term than COO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

COO’s TA Score shows that 5 TA indicator(s) are bullish while WAT’s TA Score has 6 bullish TA indicator(s).

  • COO’s TA Score: 5 bullish, 4 bearish.
  • WAT’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, WAT is a better buy in the short-term than COO.

Price Growth

COO (@Medical Specialties) experienced а -3.52% price change this week, while WAT (@Medical Specialties) price change was -1.35% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -1.13%. For the same industry, the average monthly price growth was +4.30%, and the average quarterly price growth was -3.02%.

Reported Earning Dates

COO is expected to report earnings on Dec 05, 2024.

WAT is expected to report earnings on Feb 11, 2025.

Industries' Descriptions

@Medical Specialties (-1.13% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
WAT($20.4B) and COO($19.7B) have the same market capitalization . COO has higher P/E ratio than WAT: COO (68.09) vs WAT (31.78). COO YTD gains are higher at: 11.954 vs. WAT (7.071). WAT has higher annual earnings (EBITDA): 1B vs. COO (895M). WAT has more cash in the bank: 396M vs. COO (135M). WAT has less debt than COO: WAT (2.44B) vs COO (2.77B). COO has higher revenues than WAT: COO (3.67B) vs WAT (2.96B).
COOWATCOO / WAT
Capitalization19.7B20.4B97%
EBITDA895M1B89%
Gain YTD11.9547.071169%
P/E Ratio68.0931.78214%
Revenue3.67B2.96B124%
Total Cash135M396M34%
Total Debt2.77B2.44B114%
FUNDAMENTALS RATINGS
COO vs WAT: Fundamental Ratings
COO
WAT
OUTLOOK RATING
1..100
8512
VALUATION
overvalued / fair valued / undervalued
1..100
89
Overvalued
82
Overvalued
PROFIT vs RISK RATING
1..100
5148
SMR RATING
1..100
8419
PRICE GROWTH RATING
1..100
2825
P/E GROWTH RATING
1..100
6024
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

WAT's Valuation (82) in the Medical Specialties industry is in the same range as COO (89). This means that WAT’s stock grew similarly to COO’s over the last 12 months.

WAT's Profit vs Risk Rating (48) in the Medical Specialties industry is in the same range as COO (51). This means that WAT’s stock grew similarly to COO’s over the last 12 months.

WAT's SMR Rating (19) in the Medical Specialties industry is somewhat better than the same rating for COO (84). This means that WAT’s stock grew somewhat faster than COO’s over the last 12 months.

WAT's Price Growth Rating (25) in the Medical Specialties industry is in the same range as COO (28). This means that WAT’s stock grew similarly to COO’s over the last 12 months.

WAT's P/E Growth Rating (24) in the Medical Specialties industry is somewhat better than the same rating for COO (60). This means that WAT’s stock grew somewhat faster than COO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
COOWAT
RSI
ODDS (%)
Bearish Trend 3 days ago
59%
Bearish Trend 3 days ago
39%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
69%
Bearish Trend 3 days ago
59%
Momentum
ODDS (%)
Bearish Trend 3 days ago
54%
Bullish Trend 3 days ago
65%
MACD
ODDS (%)
Bearish Trend 3 days ago
51%
Bullish Trend 3 days ago
74%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
54%
Bearish Trend 3 days ago
63%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
61%
Bullish Trend 3 days ago
66%
Advances
ODDS (%)
Bullish Trend 7 days ago
65%
Bullish Trend 7 days ago
65%
Declines
ODDS (%)
Bearish Trend 3 days ago
54%
Bearish Trend 3 days ago
59%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
62%
Bearish Trend 3 days ago
48%
Aroon
ODDS (%)
Bullish Trend 3 days ago
58%
Bullish Trend 3 days ago
66%
View a ticker or compare two or three
Ad is loading...
COO
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
WAT
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ZLAB26.361.74
+7.07%
Zai Lab Limited
SILO1.060.04
+3.92%
Silo Pharma
MNTK5.410.05
+0.93%
Montauk Renewables
Z62.78-0.99
-1.55%
Zillow Group
CMBM1.64-0.10
-5.75%
Cambium Networks Corp

COO and

Correlation & Price change

A.I.dvisor indicates that over the last year, COO has been loosely correlated with ALC. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if COO jumps, then ALC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To COO
1D Price
Change %
COO100%
-0.98%
ALC - COO
55%
Loosely correlated
-0.86%
STE - COO
53%
Loosely correlated
-0.79%
WAT - COO
47%
Loosely correlated
-0.53%
TFX - COO
43%
Loosely correlated
-0.15%
A - COO
42%
Loosely correlated
+0.29%
More

WAT and

Correlation & Price change

A.I.dvisor indicates that over the last year, WAT has been closely correlated with A. These tickers have moved in lockstep 85% of the time. This A.I.-generated data suggests there is a high statistical probability that if WAT jumps, then A could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To WAT
1D Price
Change %
WAT100%
-0.53%
A - WAT
85%
Closely correlated
+0.29%
MTD - WAT
75%
Closely correlated
-0.72%
TMO - WAT
69%
Closely correlated
-0.38%
BRKR - WAT
66%
Loosely correlated
+1.82%
DHR - WAT
63%
Loosely correlated
-0.18%
More